25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

XTNT (Xtant Medical Holdings Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Xtant Medical Holdings Inc together

I guess you are interested in Xtant Medical Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Xtant Medical Holdings Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Xtant Medical Holdings Inc’s Price Targets

I'm going to help you getting a better view of Xtant Medical Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Xtant Medical Holdings Inc

I send you an email if I find something interesting about Xtant Medical Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Xtant Medical Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of Xtant Medical Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.31
Expected worth in 1 year
$0.27
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.04
Return On Investment
-5.5%

For what price can you sell your share?

Current Price per Share
$0.66
Expected price per share
$0.54 - $0.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Xtant Medical Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$0.66
Intrinsic Value Per Share
$-0.36 - $0.20
Total Value Per Share
$-0.06 - $0.51

2.2. Growth of Xtant Medical Holdings Inc (5 min.)




Is Xtant Medical Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$43.8m$46.1m-$1.7m-4.0%

How much money is Xtant Medical Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$415.5k-$2.5m-86.1%
Net Profit Margin-10.2%-1.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Xtant Medical Holdings Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#159 / 292

Most Revenue
#121 / 292

Most Profit
#181 / 292

Most Efficient
#148 / 292
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Xtant Medical Holdings Inc?

Welcome investor! Xtant Medical Holdings Inc's management wants to use your money to grow the business. In return you get a share of Xtant Medical Holdings Inc.

First you should know what it really means to hold a share of Xtant Medical Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Xtant Medical Holdings Inc is $0.655. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xtant Medical Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xtant Medical Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.31. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xtant Medical Holdings Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.1%-0.02-3.3%0.00-0.5%-0.01-2.0%-0.01-1.8%-0.04-6.2%
Usd Book Value Change Per Share0.00-0.3%-0.01-1.4%0.034.1%0.011.2%0.034.9%0.011.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.3%-0.01-1.4%0.034.1%0.011.2%0.034.9%0.011.5%
Usd Price Per Share0.47-0.55-1.08-0.76-0.92-1.67-
Price to Earnings Ratio290.38-68.79--7.26-16.98--142.08--81.64-
Price-to-Total Gains Ratio-208.43--33.16--39.80--27.39--26.42--37.08-
Price to Book Ratio1.54-1.74-3.37-2.62-3.25--10.86-
Price-to-Total Gains Ratio-208.43--33.16--39.80--27.39--26.42--37.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.655
Number of shares1526
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.03
Usd Total Gains Per Share-0.010.03
Gains per Quarter (1526 shares)-13.7848.81
Gains per Year (1526 shares)-55.11195.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-55-650195185
20-110-1200390380
30-165-1750586575
40-220-2300781770
50-276-2850976965
60-331-340011711160
70-386-395013671355
80-441-450015621550
90-496-505017571745
100-551-560019521940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%3.037.00.07.5%6.060.00.09.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%13.027.00.032.5%23.041.02.034.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.065.01.5%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%13.027.00.032.5%23.041.02.034.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Xtant Medical Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.009+300%0.027-108%0.008-128%0.032-107%0.010-124%
Book Value Per Share--0.3060.316-3%0.331-8%0.292+5%0.204+50%0.047+557%
Current Ratio--2.3372.311+1%2.604-10%2.713-14%2.930-20%2.673-13%
Debt To Asset Ratio--0.5420.538+1%0.467+16%0.485+12%0.644-16%0.984-45%
Debt To Equity Ratio--1.1841.164+2%0.891+33%0.958+24%0.859+38%2.373-50%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--20443503.58031817868.887-36%115396423.085-82%74779064.548-73%97997498.203-79%162893193.313-87%
Eps--0.000-0.022+5419%-0.003+837%-0.013+3353%-0.012+3080%-0.041+10143%
Ev To Ebitda Ratio--2.392-3.164+232%-22.301+1032%-12.976+643%-11.462+579%96.120-98%
Ev To Sales Ratio--0.1550.267-42%1.149-86%0.887-82%1.522-90%2.504-94%
Free Cash Flow Per Share--0.001-0.017+2878%-0.027+4475%-0.019+3304%-0.013+2223%-0.012+2153%
Free Cash Flow To Equity Per Share---0.0060.001-635%0.010-159%0.007-185%0.009-166%0.017-134%
Gross Profit Margin---192.172-44.925-77%2.403-8098%-12.857-93%2.473-7870%2.717-7173%
Intrinsic Value_10Y_max--0.203----------
Intrinsic Value_10Y_min---0.363----------
Intrinsic Value_1Y_max---0.040----------
Intrinsic Value_1Y_min---0.071----------
Intrinsic Value_3Y_max---0.074----------
Intrinsic Value_3Y_min---0.185----------
Intrinsic Value_5Y_max---0.052----------
Intrinsic Value_5Y_min---0.266----------
Market Cap91256570.240+26%67367503.58077656368.887-13%150813673.085-55%105609564.548-36%127870898.203-47%232852405.538-71%
Net Profit Margin--0.002-0.102+5879%-0.013+812%-0.083+4794%-0.095+5463%-0.220+12564%
Operating Margin--0.032-0.065+302%-0.082+355%-0.083+358%-0.069+314%-0.094+390%
Operating Ratio--0.9681.065-9%1.214-20%1.128-14%1.096-12%1.094-12%
Pb Ratio2.140+28%1.5351.743-12%3.368-54%2.624-41%3.248-53%-10.865+808%
Pe Ratio404.675+28%290.37768.791+322%-7.262+103%16.982+1610%-142.084+149%-81.640+128%
Price Per Share0.655+28%0.4700.554-15%1.082-57%0.757-38%0.917-49%1.671-72%
Price To Free Cash Flow Ratio269.783+28%193.585-501.455+359%-14.380+107%-178.991+192%-119.976+162%-85.085+144%
Price To Total Gains Ratio-290.473-39%-208.431-33.157-84%-39.802-81%-27.395-87%-26.418-87%-37.077-82%
Quick Ratio--0.9640.912+6%1.035-7%1.279-25%1.395-31%1.229-22%
Return On Assets--0.001-0.031+5236%-0.007+1197%-0.025+4159%-0.027+4491%-0.064+10663%
Return On Equity--0.001-0.067+5169%-0.020+1575%-0.051+3925%-0.044+3439%-0.058+4476%
Total Gains Per Share---0.002-0.009+300%0.027-108%0.008-128%0.032-107%0.010-124%
Usd Book Value--43877000.00044392500.000-1%46167250.000-5%40836416.667+7%28488250.000+54%6519338.800+573%
Usd Book Value Change Per Share---0.002-0.009+300%0.027-108%0.008-128%0.032-107%0.010-124%
Usd Book Value Per Share--0.3060.316-3%0.331-8%0.292+5%0.204+50%0.047+557%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--20443503.58031817868.887-36%115396423.085-82%74779064.548-73%97997498.203-79%162893193.313-87%
Usd Eps--0.000-0.022+5419%-0.003+837%-0.013+3353%-0.012+3080%-0.041+10143%
Usd Free Cash Flow--87000.000-2348500.000+2799%-3699500.000+4352%-2709166.667+3214%-1795150.000+2163%-1736402.700+2096%
Usd Free Cash Flow Per Share--0.001-0.017+2878%-0.027+4475%-0.019+3304%-0.013+2223%-0.012+2153%
Usd Free Cash Flow To Equity Per Share---0.0060.001-635%0.010-159%0.007-185%0.009-166%0.017-134%
Usd Market Cap91256570.240+26%67367503.58077656368.887-13%150813673.085-55%105609564.548-36%127870898.203-47%232852405.538-71%
Usd Price Per Share0.655+28%0.4700.554-15%1.082-57%0.757-38%0.917-49%1.671-72%
Usd Profit--58000.000-2998000.000+5269%-415500.000+816%-1833666.667+3261%-1679900.000+2996%-4011081.300+7016%
Usd Revenue--32904000.00030574250.000+8%25308000.000+30%23873416.667+38%19663200.000+67%19253623.525+71%
Usd Total Gains Per Share---0.002-0.009+300%0.027-108%0.008-128%0.032-107%0.010-124%
 EOD+3 -5MRQTTM+21 -17YOY+15 -233Y+18 -205Y+19 -1910Y+18 -20

3.3 Fundamental Score

Let's check the fundamental score of Xtant Medical Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15404.675
Price to Book Ratio (EOD)Between0-12.140
Net Profit Margin (MRQ)Greater than00.002
Operating Margin (MRQ)Greater than00.032
Quick Ratio (MRQ)Greater than10.964
Current Ratio (MRQ)Greater than12.337
Debt to Asset Ratio (MRQ)Less than10.542
Debt to Equity Ratio (MRQ)Less than11.184
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Xtant Medical Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.680
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Xtant Medical Holdings Inc

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Fundamental data was last updated by Penke on 2025-07-03 12:55:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Xtant Medical Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • A Net Profit Margin of 0.2%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.2%. The company is not making a profit/loss.
  • The TTM is -10.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-10.2%+10.4%
TTM-10.2%YOY-1.3%-8.9%
TTM-10.2%5Y-9.5%-0.7%
5Y-9.5%10Y-22.0%+12.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-7.9%+8.1%
TTM-10.2%-10.4%+0.2%
YOY-1.3%-13.5%+12.2%
3Y-8.3%-14.5%+6.2%
5Y-9.5%-10.7%+1.2%
10Y-22.0%-11.1%-10.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Xtant Medical Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • 0.1% Return on Assets means thatΒ Xtant Medical Holdings Inc generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-3.1%+3.2%
TTM-3.1%YOY-0.7%-2.4%
TTM-3.1%5Y-2.7%-0.5%
5Y-2.7%10Y-6.4%+3.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-2.1%+2.2%
TTM-3.1%-2.4%-0.7%
YOY-0.7%-3.5%+2.8%
3Y-2.5%-2.9%+0.4%
5Y-2.7%-2.7%+0.0%
10Y-6.4%-2.4%-4.0%
4.3.1.3. Return on Equity

Shows how efficient Xtant Medical Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • 0.1% Return on Equity means Xtant Medical Holdings Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -6.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-6.7%+6.8%
TTM-6.7%YOY-2.0%-4.8%
TTM-6.7%5Y-4.4%-2.3%
5Y-4.4%10Y-5.8%+1.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-2.0%+2.1%
TTM-6.7%-3.2%-3.5%
YOY-2.0%-3.9%+1.9%
3Y-5.1%-4.0%-1.1%
5Y-4.4%-4.4%0.0%
10Y-5.8%-6.3%+0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Xtant Medical Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Xtant Medical Holdings Inc is operatingΒ .

  • Measures how much profit Xtant Medical Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • An Operating Margin of 3.2%Β means the company generated $0.03 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Xtant Medical Holdings Inc:

  • The MRQ is 3.2%. The company is operating less efficient.
  • The TTM is -6.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ3.2%TTM-6.5%+9.8%
TTM-6.5%YOY-8.2%+1.7%
TTM-6.5%5Y-6.9%+0.4%
5Y-6.9%10Y-9.4%+2.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%-12.1%+15.3%
TTM-6.5%-13.7%+7.2%
YOY-8.2%-11.9%+3.7%
3Y-8.3%-11.3%+3.0%
5Y-6.9%-10.3%+3.4%
10Y-9.4%-12.2%+2.8%
4.3.2.2. Operating Ratio

Measures how efficient Xtant Medical Holdings Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.968. The company is less efficient in keeping operating costs low.
  • The TTM is 1.065. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.968TTM1.065-0.098
TTM1.065YOY1.214-0.148
TTM1.0655Y1.096-0.030
5Y1.09610Y1.094+0.001
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9681.397-0.429
TTM1.0651.389-0.324
YOY1.2141.295-0.081
3Y1.1281.342-0.214
5Y1.0961.375-0.279
10Y1.0941.328-0.234
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Xtant Medical Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Xtant Medical Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 2.34Β means the company has $2.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Xtant Medical Holdings Inc:

  • The MRQ is 2.337. The company is able to pay all its short-term debts. +1
  • The TTM is 2.311. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.337TTM2.311+0.027
TTM2.311YOY2.604-0.293
TTM2.3115Y2.930-0.619
5Y2.93010Y2.673+0.257
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3372.473-0.136
TTM2.3112.589-0.278
YOY2.6042.630-0.026
3Y2.7132.884-0.171
5Y2.9303.528-0.598
10Y2.6733.291-0.618
4.4.3.2. Quick Ratio

Measures if Xtant Medical Holdings Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • A Quick Ratio of 0.96Β means the company can pay off $0.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.964. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.912. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.964TTM0.912+0.052
TTM0.912YOY1.035-0.123
TTM0.9125Y1.395-0.483
5Y1.39510Y1.229+0.167
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9641.079-0.115
TTM0.9121.398-0.486
YOY1.0351.638-0.603
3Y1.2791.815-0.536
5Y1.3952.139-0.744
10Y1.2292.338-1.109
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Xtant Medical Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Xtant Medical Holdings IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Xtant Medical Holdings Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.54Β means that Xtant Medical Holdings Inc assets areΒ financed with 54.2% credit (debt) and the remaining percentage (100% - 54.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Xtant Medical Holdings Inc:

  • The MRQ is 0.542. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.538. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.542TTM0.538+0.004
TTM0.538YOY0.467+0.071
TTM0.5385Y0.644-0.107
5Y0.64410Y0.984-0.340
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5420.409+0.133
TTM0.5380.419+0.119
YOY0.4670.401+0.066
3Y0.4850.391+0.094
5Y0.6440.424+0.220
10Y0.9840.457+0.527
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Xtant Medical Holdings Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 118.4% means that company has $1.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Xtant Medical Holdings Inc:

  • The MRQ is 1.184. The company is able to pay all its debts with equity. +1
  • The TTM is 1.164. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.184TTM1.164+0.020
TTM1.164YOY0.891+0.273
TTM1.1645Y0.859+0.305
5Y0.85910Y2.373-1.514
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1840.608+0.576
TTM1.1640.648+0.516
YOY0.8910.623+0.268
3Y0.9580.644+0.314
5Y0.8590.683+0.176
10Y2.3730.757+1.616
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Xtant Medical Holdings Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Xtant Medical Holdings Inc to theΒ Medical Devices industry mean.
  • A PE ratio of 290.38 means the investor is paying $290.38Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Xtant Medical Holdings Inc:

  • The EOD is 404.675. Based on the earnings, the company is expensive. -2
  • The MRQ is 290.377. Based on the earnings, the company is expensive. -2
  • The TTM is 68.791. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD404.675MRQ290.377+114.297
MRQ290.377TTM68.791+221.586
TTM68.791YOY-7.262+76.053
TTM68.7915Y-142.084+210.875
5Y-142.08410Y-81.640-60.444
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD404.675-1.295+405.970
MRQ290.377-1.518+291.895
TTM68.791-1.257+70.048
YOY-7.262-2.406-4.856
3Y16.982-1.572+18.554
5Y-142.084-1.938-140.146
10Y-81.640-1.705-79.935
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Xtant Medical Holdings Inc:

  • The EOD is 269.783. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 193.585. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -501.455. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD269.783MRQ193.585+76.198
MRQ193.585TTM-501.455+695.040
TTM-501.455YOY-14.380-487.075
TTM-501.4555Y-119.976-381.479
5Y-119.97610Y-85.085-34.892
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD269.783-2.842+272.625
MRQ193.585-3.183+196.768
TTM-501.455-1.612-499.843
YOY-14.380-3.401-10.979
3Y-178.991-2.458-176.533
5Y-119.976-3.239-116.737
10Y-85.085-3.398-81.687
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Xtant Medical Holdings Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 1.54 means the investor is paying $1.54Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Xtant Medical Holdings Inc:

  • The EOD is 2.140. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.535. Based on the equity, the company is underpriced. +1
  • The TTM is 1.743. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.140MRQ1.535+0.604
MRQ1.535TTM1.743-0.208
TTM1.743YOY3.368-1.625
TTM1.7435Y3.248-1.505
5Y3.24810Y-10.865+14.112
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.1402.030+0.110
MRQ1.5351.966-0.431
TTM1.7432.162-0.419
YOY3.3682.656+0.712
3Y2.6242.683-0.059
5Y3.2483.822-0.574
10Y-10.8654.189-15.054
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Xtant Medical Holdings Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Income before Tax  -4,332507-3,825-1,137-4,9621,818-3,1443,17733
Net Income  -4,400539-3,861-1,163-5,0241,859-3,1653,22358
EBIT  -3,497664-2,833-930-3,7631,753-2,0103,0731,063
EBITDA  -2,492657-1,835-855-2,6901,828-8622,9992,137
Operating Income  -3,470524-2,946-831-3,7771,895-1,8822,9451,063
Tax Provision  68-32362662-4121-46-25
Net Income from Continuing Operations  -4,400539-3,861-1,163-5,0241,859-3,1653,22358



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets95,833
Total Liabilities51,956
Total Stockholder Equity43,877
 As reported
Total Liabilities 51,956
Total Stockholder Equity+ 43,877
Total Assets = 95,833

Assets

Total Assets95,833
Total Current Assets69,144
Long-term Assets26,689
Total Current Assets
Cash And Cash Equivalents 5,032
Net Receivables 23,476
Inventory 38,812
Other Current Assets 1,824
Total Current Assets  (as reported)69,144
Total Current Assets  (calculated)69,144
+/-0
Long-term Assets
Property Plant Equipment 11,462
Goodwill 7,302
Intangible Assets 7,924
Long-term Assets Other 1
Long-term Assets  (as reported)26,689
Long-term Assets  (calculated)26,689
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,581
Long-term Liabilities22,375
Total Stockholder Equity43,877
Total Current Liabilities
Short-term Debt 11,968
Short Long Term Debt 11,261
Accounts payable 7,121
Other Current Liabilities 3,371
Total Current Liabilities  (as reported)29,581
Total Current Liabilities  (calculated)33,721
+/- 4,140
Long-term Liabilities
Long term Debt 22,167
Capital Lease Obligations 867
Long-term Liabilities  (as reported)22,375
Long-term Liabilities  (calculated)23,034
+/- 659
Total Stockholder Equity
Retained Earnings -259,401
Accumulated Other Comprehensive Income -209
Other Stockholders Equity 303,487
Total Stockholder Equity (as reported)43,877
Total Stockholder Equity (calculated)43,877
+/-0
Other
Cash and Short Term Investments 5,032
Common Stock Shares Outstanding 143,335
Liabilities and Stockholders Equity 95,833
Net Debt 7,096
Net Invested Capital 77,305
Net Working Capital 39,563
Property Plant and Equipment Gross 31,962
Short Long Term Debt Total 12,128



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-30
> Total Assets 
0
140
0
0
91
138
103
15,393
14,601
15,764
17,060
19,755
23,408
23,170
26,710
28,453
38,447
34,496
32,746
35,119
31,039
28,878
31,233
28,417
31,813
27,951
27,405
26,352
126,227
143,059
141,391
141,306
142,449
144,102
139,688
134,294
128,456
139,688
104,782
102,785
99,270
46,422
47,065
44,497
43,037
43,155
42,551
41,666
42,394
41,466
58,697
59,676
55,791
54,692
53,170
52,713
56,049
60,229
63,316
65,218
92,003
92,612
93,931
95,578
98,882
93,837
95,833
95,83393,83798,88295,57893,93192,61292,00365,21863,31660,22956,04952,71353,17054,69255,79159,67658,69741,46642,39441,66642,55143,15543,03744,49747,06546,42299,270102,785104,782139,688128,456134,294139,688144,102142,449141,306141,391143,059126,22726,35227,40527,95131,81328,41731,23328,87831,03935,11932,74634,49638,44728,45326,71023,17023,40819,75517,06015,76414,60115,39310313891001400
   > Total Current Assets 
0
140
0
0
91
138
103
11,760
10,845
10,475
12,019
14,467
17,042
16,604
19,799
20,684
29,840
25,575
23,635
25,834
21,786
19,169
21,778
19,415
23,195
19,108
18,991
18,026
44,371
45,423
44,654
43,731
45,768
48,986
46,817
43,275
40,682
46,817
40,131
39,700
37,858
34,677
33,580
32,303
31,609
32,246
32,110
31,389
32,385
31,365
48,476
49,432
45,588
44,330
42,760
42,332
45,108
49,318
36,587
39,571
64,107
64,869
66,541
68,972
71,410
67,116
69,144
69,14467,11671,41068,97266,54164,86964,10739,57136,58749,31845,10842,33242,76044,33045,58849,43248,47631,36532,38531,38932,11032,24631,60932,30333,58034,67737,85839,70040,13146,81740,68243,27546,81748,98645,76843,73144,65445,42344,37118,02618,99119,10823,19519,41521,77819,16921,78625,83423,63525,57529,84020,68419,79916,60417,04214,46712,01910,47510,84511,76010313891001400
       Cash And Cash Equivalents 
0
44
0
0
17
46
62
3,127
572
327
375
1,402
1,815
751
1,364
1,214
8,616
4,926
2,119
5,136
3,438
3,046
4,769
2,989
6,953
4,468
2,900
2,026
7,970
6,368
4,668
2,217
1,409
2,578
2,487
1,665
2,069
2,487
6,172
6,049
5,064
6,797
7,097
7,318
5,749
5,237
3,239
3,019
2,741
2,341
18,643
20,312
18,175
18,243
16,848
16,495
17,363
20,298
5,410
4,138
8,664
5,715
4,624
5,379
6,596
6,199
5,032
5,0326,1996,5965,3794,6245,7158,6644,1385,41020,29817,36316,49516,84818,24318,17520,31218,6432,3412,7413,0193,2395,2375,7497,3187,0976,7975,0646,0496,1722,4872,0691,6652,4872,5781,4092,2174,6686,3687,9702,0262,9004,4686,9532,9894,7693,0463,4385,1362,1194,9268,6161,2141,3647511,8151,4023753275723,12762461700440
       Net Receivables 
0
59
0
0
19
1,585
6
1,948
2,561
4,135
4,239
5,493
7,105
7,083
7,603
6,583
7,185
7,154
7,164
6,227
4,633
4,794
5,529
4,898
4,294
4,427
5,496
5,574
13,318
15,385
14,923
14,725
15,826
18,992
16,320
15,847
13,909
16,320
10,340
10,404
9,869
9,990
9,493
8,565
9,121
10,124
9,743
7,583
7,317
6,880
7,027
6,985
6,321
7,154
7,545
8,600
9,839
10,853
11,902
13,744
19,150
20,731
21,484
21,187
20,545
20,660
23,476
23,47620,66020,54521,18721,48420,73119,15013,74411,90210,8539,8398,6007,5457,1546,3216,9857,0276,8807,3177,5839,74310,1249,1218,5659,4939,9909,86910,40410,34016,32013,90915,84716,32018,99215,82614,72514,92315,38513,3185,5745,4964,4274,2944,8985,5294,7944,6336,2277,1647,1547,1856,5837,6037,0837,1055,4934,2394,1352,5611,94861,5851900590
       Other Current Assets 
0
10
0
0
14
-1,512
5
778
740
572
1,172
1,146
411
289
421
586
1,261
707
743
668
487
575
982
1,010
808
654
885
1,034
1,040
985
858
1,279
4,068
1,150
1,651
1,662
1,329
3,302
2,214
1,602
1,476
589
892
592
1,379
1,568
2,168
1,798
1,656
1,472
2,330
1,042
1,384
988
1,067
776
913
1,555
1,740
2,340
3,833
1,330
1,786
1,899
2,383
1,623
1,824
1,8241,6232,3831,8991,7861,3303,8332,3401,7401,5559137761,0679881,3841,0422,3301,4721,6561,7982,1681,5681,3795928925891,4761,6022,2143,3021,3291,6621,6511,1504,0681,2798589851,0401,0348856548081,0109825754876687437071,2615864212894111,1461,1725727407785-1,5121400100
   > Long-term Assets 
0
0
0
0
0
0
0
3,633
3,757
0
5,042
5,288
6,366
6,566
6,911
7,769
8,606
8,921
9,111
9,286
9,253
9,709
9,456
9,002
8,618
8,843
8,414
8,326
81,856
97,636
96,737
97,575
96,681
95,115
92,870
91,019
87,775
92,870
64,651
63,085
61,412
11,745
13,485
12,194
11,428
10,909
10,441
10,277
10,009
10,101
10,221
10,244
10,203
10,362
10,410
10,381
10,941
10,911
26,729
25,647
27,896
27,743
27,390
26,606
27,472
26,721
26,689
26,68926,72127,47226,60627,39027,74327,89625,64726,72910,91110,94110,38110,41010,36210,20310,24410,22110,10110,00910,27710,44110,90911,42812,19413,48511,74561,41263,08564,65192,87087,77591,01992,87095,11596,68197,57596,73797,63681,8568,3268,4148,8438,6189,0029,4569,7099,2539,2869,1118,9218,6067,7696,9116,5666,3665,2885,04203,7573,6330000000
       Property Plant Equipment 
0
0
0
0
0
0
0
2,985
3,117
3,398
3,407
3,394
3,477
3,774
4,095
4,450
4,883
5,235
5,527
5,458
5,321
5,181
5,014
4,888
4,767
4,655
4,503
4,430
11,433
11,817
13,773
15,618
16,012
15,841
15,220
14,037
11,451
15,220
9,331
8,928
8,069
7,174
8,950
7,896
7,266
6,795
6,302
6,154
5,921
6,037
6,251
6,346
6,340
6,470
6,555
6,562
7,159
7,165
8,095
8,030
10,691
10,215
10,304
9,954
11,279
10,960
11,462
11,46210,96011,2799,95410,30410,21510,6918,0308,0957,1657,1596,5626,5556,4706,3406,3466,2516,0375,9216,1546,3026,7957,2667,8968,9507,1748,0698,9289,33115,22011,45114,03715,22015,84116,01215,61813,77311,81711,4334,4304,5034,6554,7674,8885,0145,1815,3215,4585,5275,2354,8834,4504,0953,7743,4773,3943,4073,3983,1172,9850000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
729
729
729
729
729
729
729
729
729
0
0
0
0
0
0
0
23,997
41,535
41,535
41,535
41,535
41,535
41,535
41,535
41,535
41,535
41,535
41,535
41,535
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
3,205
7,639
6,514
6,514
7,302
7,302
7,302
7,302
7,302
7,302
7,3027,3027,3027,3027,3027,3026,5146,5147,6393,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,20541,53541,53541,53541,53541,53541,53541,53541,53541,53541,53541,53541,53523,9970000000729729729729729729729729729000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
82
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000008200000000000
       Intangible Assets 
0
0
0
0
0
0
0
553
541
356
417
446
669
656
637
617
587
592
578
565
564
587
617
626
649
655
621
609
42,224
40,237
39,219
38,123
37,021
35,941
34,801
33,673
32,548
34,801
12,977
12,106
11,248
573
558
544
529
515
500
486
471
457
443
428
414
400
386
372
358
344
10,810
10,920
10,492
10,085
9,652
9,220
8,788
8,356
7,924
7,9248,3568,7889,2209,65210,08510,49210,92010,81034435837238640041442844345747148650051552954455857311,24812,10612,97734,80132,54833,67334,80135,94137,02138,12339,21940,23742,2246096216556496266175875645655785925876176376566694464173565415530000000
       Other Assets 
0
0
0
0
0
0
0
649
639
1,891
1,634
1,893
2,890
2,792
2,816
3,320
3,724
3,686
3,585
3,828
3,933
4,528
4,442
0
3,850
4,188
3,910
3,896
70,423
85,819
82,964
81,957
80,669
0
77,651
76,982
76,323
56,287
808
516
560
793
772
549
428
394
434
432
412
2,092
322
265
244
287
264
242
219
197
0
183
0
0
0
0
0
0
0
000000018301972192422642872442653222,09241243243439442854977279356051680856,28776,32376,98277,651080,66981,95782,96485,81970,4233,8963,9104,1883,85004,4424,5283,9333,8283,5853,6863,7243,3202,8162,7922,8901,8931,6341,8916396490000000
> Total Liabilities 
0
128
0
0
16
41
15
7,094
13,487
16,383
11,223
10,788
14,723
17,669
17,725
18,310
29,855
30,263
30,089
31,683
31,675
32,720
37,799
36,375
36,271
35,726
37,876
38,200
129,058
134,183
138,030
141,802
147,548
151,175
151,362
155,587
158,685
151,362
89,172
92,497
86,615
90,194
86,241
85,573
85,896
87,360
89,027
88,524
90,375
26,952
25,331
25,792
23,154
23,809
23,887
24,569
23,276
26,058
30,606
34,259
37,322
41,263
46,251
50,573
53,157
50,874
51,956
51,95650,87453,15750,57346,25141,26337,32234,25930,60626,05823,27624,56923,88723,80923,15425,79225,33126,95290,37588,52489,02787,36085,89685,57386,24190,19486,61592,49789,172151,362158,685155,587151,362151,175147,548141,802138,030134,183129,05838,20037,87635,72636,27136,37537,79932,72031,67531,68330,08930,26329,85518,31017,72517,66914,72310,78811,22316,38313,4877,094154116001280
   > Total Current Liabilities 
0
128
0
0
16
41
15
6,875
13,194
14,180
7,816
6,486
7,543
10,941
11,510
11,756
8,752
8,694
8,440
9,501
8,852
9,652
11,552
9,812
9,376
8,482
10,360
10,332
16,737
21,475
25,583
25,597
28,469
31,121
28,901
20,845
87,246
28,901
11,995
12,395
10,420
12,051
11,252
9,930
9,078
9,390
10,059
9,475
9,331
25,649
24,010
12,915
10,404
11,077
11,228
11,856
11,359
15,218
17,276
16,989
21,921
22,990
28,442
28,311
33,669
28,581
29,581
29,58128,58133,66928,31128,44222,99021,92116,98917,27615,21811,35911,85611,22811,07710,40412,91524,01025,6499,3319,47510,0599,3909,0789,93011,25212,05110,42012,39511,99528,90187,24620,84528,90131,12128,46925,59725,58321,47516,73710,33210,3608,4829,3769,81211,5529,6528,8529,5018,4408,6948,75211,75611,51010,9417,5436,4867,81614,18013,1946,875154116001280
       Short-term Debt 
0
0
0
0
0
3,419
0
3,984
2,647
234
1,007
930
1,112
1,667
2,354
4,347
220
195
201
207
213
220
219
196
159
113
82
95
100
35
30
5,684
8,773
10,938
10,553
604
65,929
10,812
766
938
956
640
1,524
1,696
1,232
1,140
1,078
1,018
948
17,683
17,412
5,019
4,452
4,606
4,611
4,814
3,063
6,752
8,796
6,841
8,426
0
11,189
13,621
17,363
12,892
11,968
11,96812,89217,36313,62111,18908,4266,8418,7966,7523,0634,8144,6114,6064,4525,01917,41217,6839481,0181,0781,1401,2321,6961,52464095693876610,81265,92960410,55310,9388,7735,684303510095821131591962192202132072011952204,3472,3541,6671,1129301,0072342,6473,98403,41900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
0
0
0
110,711
0
0
0
130,747
10,716
135,043
65,610
138,951
77,560
80,251
0
0
374
0
0
0
0
0
0
16,797
16,490
4,077
3,488
3,620
3,607
3,736
2,055
5,712
7,724
5,739
6,832
4,622
10,270
11,899
15,637
12,120
11,261
11,26112,12015,63711,89910,2704,6226,8325,7397,7245,7122,0553,7363,6073,6203,4884,07716,49016,7970000003740080,25177,560138,95165,610135,04310,716130,747000110,711000510000000000000000000000000
       Accounts payable 
0
51
0
0
4
1,404
13
1,522
1,750
2,833
3,229
2,479
2,210
2,654
3,865
3,606
4,055
3,998
3,982
4,246
3,225
2,768
4,250
4,249
3,893
3,877
4,412
4,577
7,485
9,387
12,389
12,787
12,889
10,472
8,896
8,446
7,350
8,896
7,528
7,526
5,918
11,615
6,036
3,194
2,249
2,188
3,609
3,072
2,814
2,289
2,490
2,639
2,355
2,615
2,774
3,043
3,779
3,490
3,421
4,444
5,358
7,054
7,378
6,875
8,298
7,918
7,121
7,1217,9188,2986,8757,3787,0545,3584,4443,4213,4903,7793,0432,7742,6152,3552,6392,4902,2892,8143,0723,6092,1882,2493,1946,03611,6155,9187,5267,5288,8967,3508,4468,89610,47212,88912,78712,3899,3877,4854,5774,4123,8773,8934,2494,2502,7683,2254,2463,9823,9984,0553,6063,8652,6542,2102,4793,2292,8331,7501,522131,404400510
       Other Current Liabilities 
0
77
0
0
12
-4,783
2
763
8,798
11,083
-790
3,077
4,221
6,620
5,292
3,803
4,477
4,502
4,258
5,048
5,414
6,664
7,083
5,367
5,324
4,493
5,865
5,659
9,152
12,053
13,164
7,125
6,808
9,711
164
11,795
13,967
9,193
3,701
3,931
3,546
10
3,692
5,040
5,597
6,062
5,372
5,385
5,569
5,677
4,108
5,257
3,597
3,856
3,843
3,999
4,517
4,976
5,059
5,704
8,137
0
9,875
7,815
8,008
7,771
3,371
3,3717,7718,0087,8159,87508,1375,7045,0594,9764,5173,9993,8433,8563,5975,2574,1085,6775,5695,3855,3726,0625,5975,0403,692103,5463,9313,7019,19313,96711,7951649,7116,8087,12513,16412,0539,1525,6595,8654,4935,3245,3677,0836,6645,4145,0484,2584,5024,4773,8035,2926,6204,2213,077-79011,0838,7987632-4,7831200770
   > Long-term Liabilities 
0
0
0
0
0
0
2
219
293
0
3,407
4,302
7,180
6,728
6,215
6,554
21,103
21,569
21,648
22,183
22,823
23,068
26,247
26,563
26,895
27,243
27,516
27,869
112,320
112,708
112,447
116,206
119,078
120,054
122,462
134,741
71,439
122,462
77,177
80,102
76,195
77,939
74,989
75,643
76,818
77,970
78,968
79,049
81,044
1,303
1,321
12,877
12,750
12,732
12,659
12,713
11,917
10,840
13,330
17,270
15,401
18,273
17,809
22,262
19,488
22,293
22,375
22,37522,29319,48822,26217,80918,27315,40117,27013,33010,84011,91712,71312,65912,73212,75012,8771,3211,30381,04479,04978,96877,97076,81875,64374,98977,93976,19580,10277,177122,46271,439134,741122,462120,054119,078116,206112,447112,708112,32027,86927,51627,24326,89526,56326,24723,06822,82322,18321,64821,56921,1036,5546,2156,7287,1804,3023,40702932192000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
4,302
7,180
0
0
0
0
0
0
0
0
0
19,671
20,064
0
0
21,288
21,729
112,320
0
112,447
116,206
0
0
0
0
0
0
0
79,429
75,944
77,939
72,795
73,847
74,991
76,244
77,345
77,531
79,627
0
0
11,683
0
0
0
0
10,626
9,687
12,318
16,401
0
0
0
0
0
0
0
000000016,40112,3189,68710,626000011,6830079,62777,53177,34576,24474,99173,84772,79577,93975,94479,4290000000116,206112,4470112,32021,72921,2880020,06419,6710000000007,1804,30200000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,546
6,840
6,724
6,677
6,639
6,609
6,575
6,499
6,426
6,361
6,228
6,139
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000006,1396,2286,3616,4266,4996,5756,6096,6396,6776,7246,8406,5460000000000000000
> Total Stockholder Equity
0
11
0
0
75
97
88
8,300
1,114
0
5,837
8,967
8,685
5,501
8,986
10,144
8,592
4,232
2,657
3,436
-636
-3,842
-6,565
-7,958
-4,458
-7,775
-10,471
-11,848
-2,831
8,877
3,361
-496
-5,099
-7,073
-11,675
-21,292
-30,229
-11,675
15,610
10,288
12,655
-43,772
-39,176
-41,076
-42,859
-44,205
-46,476
-46,858
-47,981
14,514
33,366
33,884
32,637
30,883
29,283
28,144
32,773
34,171
32,710
30,959
54,681
51,349
47,680
45,005
45,725
42,963
43,877
43,87742,96345,72545,00547,68051,34954,68130,95932,71034,17132,77328,14429,28330,88332,63733,88433,36614,514-47,981-46,858-46,476-44,205-42,859-41,076-39,176-43,77212,65510,28815,610-11,675-30,229-21,292-11,675-7,073-5,099-4963,3618,877-2,831-11,848-10,471-7,775-4,458-7,958-6,565-3,842-6363,4362,6574,2328,59210,1448,9865,5018,6858,9675,83701,1148,30088977500110
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity0000000-247,938-245,748-243,670-241,4610000-231,098-230,365-230,336-229,630-228,270-225,806-223,266-221,661-219,783-217,844-215,045-158,353-155,521-150,198-144,946-116,526-108,012-98,319-92,5350-83,100-78,6370-84,629-77,940-75,04400-66,399-64,499000000000-35,598-32,43400000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-2,663
-2,816
-2,992
-3,139
-3,296
-3,492
-3,694
-3,889
-4,020
-4,164
-4,338
-4,519
-4,648
-4,821
-4,969
-5,108
-5,204
-5,170
-4,873
-4,996
-5,158
-5,693
-5,426
-6,067
-6,815
-7,460
-7,857
-7,936
-8,783
-11,572
-7,936
-11,750
-12,389
-12,913
-12,909
-13,600
-14,365
-15,057
-15,591
-16,187
-16,540
-16,868
0
-17,269
-17,360
0
0
0
0
0
0
0
0
-146
0
-133
-175
54
-316
-209
-209-31654-175-1330-14600000000-17,360-17,2690-16,868-16,540-16,187-15,591-15,057-14,365-13,600-12,909-12,913-12,389-11,750-7,936-11,572-8,783-7,936-7,857-7,460-6,815-6,067-5,426-5,693-5,158-4,996-4,873-5,170-5,204-5,108-4,969-4,821-4,648-4,519-4,338-4,164-4,020-3,889-3,694-3,492-3,296-3,139-2,992-2,816-2,6630000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
41,401
44,283
0
0
0
0
0
0
0
0
0
57,934
58,441
0
0
64,573
66,092
81,798
0
81,998
82,603
0
85,461
86,027
86,102
86,298
86,247
165,808
165,809
171,008
171,273
178,668
178,707
178,802
179,061
179,330
181,412
181,649
244,850
263,731
264,982
0
0
0
0
274,234
277,841
278,458
278,897
0
0
0
0
0
0
0
0000000278,897278,458277,841274,2340000264,982263,731244,850181,649181,412179,330179,061178,802178,707178,668171,273171,008165,809165,80886,24786,29886,10286,02785,461082,60381,998081,79866,09264,5730058,44157,93400000000044,28341,40100000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000-300000000
   Other Stockholders Equity 
0
19
0
0
64
22,162
97
29,471
31,327
0
37,866
41,401
44,283
45,453
49,984
50,412
51,379
51,898
51,992
55,254
60,379
56,516
57,934
63,646
63,107
63,092
64,573
66,092
87,491
81,917
81,998
89,418
90,359
93,318
93,962
86,102
86,298
86,027
165,808
178,518
171,008
0
178,668
178,707
178,802
194,652
179,330
181,412
181,649
244,850
263,731
264,982
265,539
266,068
266,681
267,252
274,234
277,841
278,458
278,897
293,534
0
295,223
296,451
301,966
302,738
303,487
303,487302,738301,966296,451295,2230293,534278,897278,458277,841274,234267,252266,681266,068265,539264,982263,731244,850181,649181,412179,330194,652178,802178,707178,6680171,008178,518165,80886,02786,29886,10293,96293,31890,35989,41881,99881,91787,49166,09264,57363,09263,10763,64657,93456,51660,37955,25451,99251,89851,37950,41249,98445,45344,28341,40137,866031,32729,4719722,1626400190



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue117,267
Cost of Revenue-49,051
Gross Profit68,21668,216
 
Operating Income (+$)
Gross Profit68,216
Operating Expense-80,290
Operating Income-12,074-12,074
 
Operating Expense (+$)
Research Development2,385
Selling General Administrative28,691
Selling And Marketing Expenses49,214
Operating Expense80,29080,290
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,160
Other Finance Cost-0
Net Interest Income-4,160
 
Pretax Income (+$)
Operating Income-12,074
Net Interest Income-4,160
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,262-7,886
EBIT - interestExpense = -16,262
-16,262
-12,289
Interest Expense4,160
Earnings Before Interest and Taxes (EBIT)-12,102-12,102
Earnings Before Interest and Taxes (EBITDA)-7,878
 
After tax Income (+$)
Income Before Tax-16,262
Tax Provision-187
Net Income From Continuing Ops-16,449-16,449
Net Income-16,449
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses129,341
Total Other Income/Expenses Net-4,1884,160
 

Technical Analysis of Xtant Medical Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xtant Medical Holdings Inc. The general trend of Xtant Medical Holdings Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xtant Medical Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Xtant Medical Holdings Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Xtant Medical Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.75 < 0.75 < 0.75.

The bearish price targets are: 0.57 > 0.54 > 0.54.

Know someone who trades $XTNT? Share this with them.πŸ‘‡

Xtant Medical Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Xtant Medical Holdings Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Xtant Medical Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartXtant Medical Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Xtant Medical Holdings Inc. The current adx is .

Xtant Medical Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Relative Strength Index (RSI) ChartXtant Medical Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Stochastic Oscillator ChartXtant Medical Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Commodity Channel Index (CCI) ChartXtant Medical Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartXtant Medical Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Williams %R ChartXtant Medical Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Average True Range (ATR) ChartXtant Medical Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily On-Balance Volume (OBV) ChartXtant Medical Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc Daily Money Flow Index (MFI) ChartXtant Medical Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Xtant Medical Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Xtant Medical Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Xtant Medical Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.680
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Xtant Medical Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on Xtant Medical Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xtant Medical Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Xtant Medical Holdings Inc

I send you an email if I find something interesting about Xtant Medical Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Xtant Medical Holdings Inc.

Receive notifications about Xtant Medical Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.